A randomized, observer-blind, placebo-controlled, multi-center, multi-national, Phase III trial evaluating the efficacy, immunogenicity, and safety of a clostridium difficile (C difficile) toxoid vaccine in subjects at risk for C difficile infection (CDI).
PRA understands how cerebrospinal fluid (CSF) sampling benefits our clients’ early phase trials. We regularly conduct CSF sampling to collect key PK…
Embedded Solutions Brochure
A campaign brochure that outlines our Embedded Solutions group and the value that they deliver to clients.
Clinical Data Management Excellence in Argentina-Your High-Value Solution
As part of our services for PRA Health Sciences’ (PRA’s) Strategic Solutions Division (SSD), we have developed multiple global biometrics-focused…